Neumora Therapeutics, Inc. Common Stock(NMRA:US)
Market Cap$77.78M
Key Metrics
Price$0.43
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$222.39M
EBITDA (TTM)-$218.98M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$147.07M
Total Assets$153.88M
Net Assets$70.68M
Total Debt$53.37M
Key Metrics
Price$0.43
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$222.39M
EBITDA (TTM)-$218.98M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$147.07M
Total Assets$153.88M
Net Assets$70.68M
Total Debt$53.37M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $52.86M | $58.48M | $57.7M | $54.04M | $70.94M | $62.92M | $76.65M | $63.82M | $60.07M | $114M | $56.86M | $42.06M | $39.17M | $30.72M | $30.6M | $31.31M | $43.24M | $26.55M | $178.13M | $17.2M | $15.45M | $19.53M | |
| Research and Development | $38.6M | $44.67M | $45.52M | $38.72M | $52.15M | $45.91M | $60.63M | $48.63M | $45.76M | $102.77M | $41.6M | $32.77M | $29.49M | $23.52M | $22.55M | $23.53M | $35.15M | $18.91M | $171.47M | $10.89M | $11.5M | $15.23M |
| Selling, General, and Administrative | $14.27M | $13.81M | $12.18M | $15.32M | $18.79M | $17.01M | $16.02M | $15.19M | $14.32M | $11.24M | $15.26M | $9.29M | $9.68M | $7.2M | $8.05M | $7.79M | $8.09M | $7.64M | $6.66M | $6.31M | $3.94M | $4.3M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$52.86M | -$58.48M | -$57.7M | -$54.04M | -$70.94M | -$62.92M | -$76.65M | -$63.82M | -$60.07M | -$114M | -$56.86M | -$42.06M | -$39.17M | -$30.72M | -$30.6M | -$31.31M | -$43.24M | -$26.55M | -$178.13M | -$17.2M | -$15.45M | -$19.53M |
| -$564K | -$970K | $945K | $1.33M | $3.05M | $4.1M | $4.15M | $5.25M | $6.35M | $5.54M | $3.84M | $3.52M | $3.54M | $2.57M | $1.26M | $942K | $194K | -$422K | $103K | $189K | $141K | -$470K | |
| Non-Operating Interest Income | $1.23M | $1.34M | $1.69M | $1.81M | $3.07M | $4.09M | $4.21M | $5.27M | $6.37M | $5.65M | $3.84M | $3.56M | $3.57M | $2.29M | $1.41M | $784K | $86K | - | - | $0 | $0 | - |
| Non-Operating Interest Expense | $1.85M | $2.04M | $747K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | $59K | -$269K | $7K | -$480K | -$25K | $15K | -$57K | -$24K | -$12K | -$104K | -$1K | -$39K | -$26K | $287K | -$148K | $158K | $108K | -$422K | $103K | $189K | $141K | -$470K |
Income Before Tax | -$53.43M | -$59.45M | -$56.76M | -$52.71M | -$67.89M | -$58.82M | -$72.49M | -$58.58M | -$53.72M | -$108.46M | -$53.03M | -$38.54M | -$35.63M | -$28.15M | -$29.34M | -$30.37M | -$43.04M | -$26.97M | -$178.03M | -$17.01M | -$15.3M | -$20M |
Income Tax | $30K | $0 | $0 | $25K | $105K | $0 | $53K | $125K | - | - | $0 | $0 | - | - | - | - | - | - | - | - | - | - |
Net Income | -$53.46M | -$59.45M | -$56.76M | -$52.73M | -$67.99M | -$58.82M | -$72.55M | -$58.7M | -$53.72M | -$108.73M | -$53.03M | -$38.54M | -$35.63M | -$28.15M | -$29.34M | -$30.37M | -$43.04M | -$26.97M | -$178.03M | -$17.01M | -$15.3M | -$20M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$53.46M | -$59.45M | -$56.76M | -$52.73M | -$67.99M | -$58.82M | -$72.55M | -$58.7M | -$53.72M | -$108.73M | -$53.03M | -$38.54M | -$35.63M | -$28.15M | -$29.34M | -$30.37M | -$43.04M | -$26.97M | -$178.03M | -$17.01M | -$15.3M | -$20M |
Shares Outstanding (Basic) | 179.87M | 168.52M | 161.84M | 161.69M | 161.45M | 160.98M | 159.58M | 158.98M | 157.94M | - | 46.69M | 151.95M | 151.95M | - | 151.95M | - | 151.95M | - | - | - | 151.95M | - |
Shares Outstanding (Diluted) | 179.87M | 168.52M | 161.84M | 161.69M | 161.45M | 160.98M | 159.58M | 158.98M | 157.94M | - | 46.69M | 151.95M | 151.95M | - | 151.95M | - | 151.95M | - | - | - | 151.95M | - |
EPS (Basic) | -$0.30 | -$0.35 | -$0.35 | -$0.33 | -$0.42 | -$0.37 | -$0.45 | -$0.37 | -$0.34 | - | -$1.14 | -$0.25 | -$0.23 | - | -$0.19 | - | -$0.28 | - | - | - | -$0.10 | - |
EPS (Diluted) | -$0.30 | -$0.35 | -$0.35 | -$0.33 | -$0.42 | -$0.37 | -$0.45 | -$0.37 | -$0.34 | - | -$1.14 | -$0.25 | -$0.23 | - | -$0.19 | - | -$0.28 | - | - | - | -$0.10 | - |
EBIT | -$51.57M | -$57.41M | -$56.01M | -$54.04M | -$70.94M | -$62.92M | -$76.65M | -$63.82M | -$60.07M | -$114M | -$56.86M | -$42.06M | -$39.17M | -$30.72M | -$30.6M | -$31.31M | -$43.24M | -$26.55M | -$178.13M | -$17.2M | -$15.45M | -$19.53M |
EBITDA | -$51.57M | -$57.41M | -$55.99M | -$54.02M | -$70.78M | -$62.77M | -$76.49M | -$63.66M | -$59.92M | -$113.84M | -$56.69M | -$41.89M | -$39.01M | -$30.57M | -$30.46M | -$31.16M | -$43.09M | -$26.42M | -$177.98M | -$17.08M | -$15.31M | -$19.47M |